TriAltus Bioscience

TriAltus Bioscience is a biotechnology company that specializes in the production of high-purity recombinant proteins and enzymes for research, diagnostics, and bioproduction. The company centers its platform on CLīM™, a proprietary purification technology based on the ultra-high-affinity CL7/Im7 system. This technology enables the rapid, single-step purification of difficult-to-isolate proteins—such as CRISPR-Cas9—while maintaining high yield, purity, and biological activity. By streamlining these workflows, the company provides scalable solutions that range from small-scale research reagents to ISO 13485-compliant manufacturing for commercial and diagnostic applications.

The company's offerings are designed to solve critical bottlenecks in protein science, allowing researchers and industry partners to avoid the time-intensive process of in-house protein production. Beyond its catalog of genomic enzymes, TriAltus provides custom protein engineering, solubility screening, and contract manufacturing services. Through its Pilot2Partnership™ program, the company assists clients in developing optimized, scalable production protocols. By delivering high-performance, cost-effective reagents, TriAltus supports critical work in drug discovery, synthetic biology, and gene therapy, serving as a trusted partner for innovators ranging from academic laboratories to large-scale diagnostic manufacturers.